Acivicin, an antimetabolite antibiotic determined' to have the structure shown ( Fig. 
produced by Streptomyces sviceus2). The biological properties and antitumor effects') of this unique amino acid have led to its recent introduction into clinical trials by the National Cancer Institute. After the straightforward production 4) of over 150 g of pure acivicin from fermentation, higher levels of contaminants were encountered which seriously hampered efforts to produce bulk supplies of the pure antitumor agent requested by the National Cancer Institute for preclinical toxicology and initial clinical trials. Although chromatographic and countercurrent separation methods were feasible for purification of modest amounts of the amino acid, its virtual insolubility in organic solvents made large-scale applications of these methods impractical. These considerations prompted an investigation of purification of acivicin via derivatization, purification of the derivative, and regeneration of the purified agent. A successful derivatization scheme required essentially quantitative derivative formation, facile derivative purification, essentially quantitative acivicin regeneration, and applicability to largescale operations. Four acivicin derivativescarbo p-nitrobenzyloxy, phthalimido, fluorenylmethoxycarbonyl, and t-butyloxycarbonyl derivatives-were examined for their suitability as purification vehicles.
The carbo p-nitrobenzyloxy derivative of acivicin, acivicin cnbz, prepared in excellent yield, was readily monitored by its UV absorption and easily purified by silica gel chromatography and/ or direct crystallization. Unfortunately, purified acivicin cnbz, m.p. 143 ti 144°C, did not efficiently provide pure acivicin on attempted removal of the carbo p-nitrobenzyloxy group. Although this group was therefore unsatisfactory for acivicin purification, its ready formation and purification and high UV visibility would make it an attractive derivative for monitoring acivicin.
The phthalimido derivative, acivicin phth, m.p. 176 -177°C, was nicely crystalline, readily monitored and purified, and efficiently released acivicin on reaction with hydrazine hydrate. Procedures developed for acivicin purification through its phthalimido derivative were subsequently utilized in a stereoselective total synthesis of acivicin") where acivicin phth was the penultimate product. Unfortunately, its formation from acivicin with N-carbethoxyphthalimides) proceeded in yields too low for consideration as a purification route for fermentation-derived acivicin.
The fluorenylmethoxycarbonyl derivative, acivicin fmoc, m.p. 175 N 176°C, was also nicely crystalline, readily monitored and purified, and amenable to acivicin regeneration on treatment with amines7) . However, its formation was accompanied by that of a by-product, unavoidable by varying reaction conditions. The crude mixture of acivicin fmoc and this by-product was resolved on silica gel with CH2Cl2 -i-PrOHHOAc (100: 3: 1). Fractions were monitored Later fractions contained a chromatographically homogeneous amorphous solid (10% yield) which, after several precipitations from acetone with cyclohexane, was consistent with acivicin dimer fmoc ( The structure was confirmed by converting acivicin fmoc into acivicin dimer fmoc by acylating acivicin with an active ester (N-hydroxyphthalimido) of acivicin fmoc. Chromatography of the resulting mixture yielded acivicin dimer fmoc (61 %) and recovered acivicin fmoc (28 %).
Surprisingly, acivicin dimer fmoc exhibited substantially greater antitumor activity than any of the monomeric derivatives. Preliminary antitumor evaluation of these derivatives is summarized in Table 1 .
The t-butyloxy carbonyl derivative, acivicin boc, was not crystalline but met the four requirements for a successful purification scheme. The conversion of impure acivicin (80 % pure by bioassay) to its BOC derivative in 50 % aqueous dioxane containing triethylaminewith2-(t-butoxycarbonyloxyimino)-2-phenylacetonitrileS) (Aldrich BOC-ON) was essentially quantitative. The extracted derivative was readily chromatographed on silica gel with CH2Cl2 -i-PrOH -HOAc (100: 3: 1) and monitored by its antimicrobial activity against Bacillus subtilis grown on a synthetic medium) and by TLC analysis on acid-treated aliquots of chromatographic fractions. Dissolving the appropriate fractions of acivicin boc in acetic acid and treating with concentrated hydrochloric acid afforded pure crystalline acivicin hydrochloride in excellent yield (87 %). Crystallization from aqueous 2-butanol or aqueous methanol after pH adjustment to pH 5.6 then yielded pure acivicin (82 % overall yield). The compounds also showed similar activity against L 1210 leukemia in mice. d In another experiment , the highest T/C observed was 1.28.
